To amend title XVIII of the Social Security Act to provide for expanded coverage of services furnished by genetic counselors under part B of the Medicare program, and for other purposes.

Bill ID: 119/hr/6280
Last Updated: November 21, 2025

Sponsored by

Rep. Smith, Adrian [R-NE-3]

ID: S001172

Bill's Journey to Becoming a Law

Track this bill's progress through the legislative process

Latest Action

Invalid Date

Introduced

📍 Current Status

Next: The bill will be reviewed by relevant committees who will debate, amend, and vote on it.

🏛️

Committee Review

🗳️

Floor Action

Passed Senate

🏛️

House Review

🎉

Passed Congress

🖊️

Presidential Action

⚖️

Became Law

📚 How does a bill become a law?

1. Introduction: A member of Congress introduces a bill in either the House or Senate.

2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.

3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.

4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.

5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.

6. Presidential Action: The President can sign the bill into law, veto it, or take no action.

7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!

Bill Summary

No summary available

💰 Campaign Finance Network

No campaign finance data available for Rep. Smith, Adrian [R-NE-3]

Industry Impact

Which industries are materially affected by specific provisions in this bill. 3 helped.

  • Section 2(a)(1)(C) adds covered genetic counseling services to Medicare Part B, and Section 2(c) sets payment at 80% of the lesser of actual charge or 85% of physician fee schedule, providing reimbursement for services that hospitals and health systems may employ genetic counselors to furnish.

  • +Biotech & Researchconfidence 0.85

    Expanded Medicare coverage for genetic counseling services increases demand for genetic testing and counseling, which benefits biotech firms involved in genetic testing, diagnostics, and related research (e.g., Moderna, Regeneron, Vertex).

  • +Medical Devicesconfidence 0.80

    Genetic counseling often involves use of diagnostic tools and genetic test kits; increased utilization under Medicare may drive demand for associated medical devices and diagnostics (e.g., Abbott, Illumina, Thermo Fisher).

Related Bills